
    
      Single centre, two-way crossover, randomised, open-label study in 20 healthy female
      volunteers.The volunteers received an oral single-dose of a combined contraceptive containing
      30 μg ethinyloestradiol and 150 μg levonorgestrel on two occasions - once as such and once
      after pre-treatment with an oral once daily dose of 1200 mg of BIA 2-093 for 15 days
      separated by a washout period of at least 3 weeks.
    
  